miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 26, 2026

ServiceNow launches Autonomous Workforce that thinks and acts; adds Moveworks to the ServiceNow AI Platform

View original at finance.yahoo.com
ServiceNow launches Autonomous Workforce that thinks and acts; adds Moveworks to the ServiceNow AI Platform AI specialists execute work with the scope, authority, and governance required for business New ServiceNow EmployeeWorks solution connects conversational AI chat and enterprise search from Moveworks with autonomo…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • ServiceNow EmployeeWorks is one of the first AI front doors that doesn't just summarize, it completes the work

    80% confidence
  • ServiceNow's Autonomous Workforce is handling 90%+ of employee IT requests at ServiceNow

    80% confidence
  • CVS Health needs AI that can handle complexity while maintaining compliance and security for 300,000 colleagues

    80% confidence
  • UKG has dozens of agentic use cases already live with Moveworks for 15,000 employees

    80% confidence
  • Businesses don't need more pilots or promises. They need AI that gets work done. The leaders realizing value from AI are investing in platforms where intelligence, execution, and trust work as one system.

    80% confidence
  • ServiceNow Now Assist is resolving 98% of initial touchpoints at City of Raleigh

    80% confidence
  • Ada AI Assistant saves Siemens Healthineers employees 5,000 hours monthly with 91% satisfaction

    80% confidence
  • The L1 Service Desk AI Specialist is 99% faster than when cases are handled by human agents

    80% confidence

Data points we hold from this source

ServiceNow · workflows run80 billion_per_year
ServiceNow · employee request automation rate90 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com